Health News

Bristol-Myers Squibb Company and the ADAP Crisis Task Force today announced an enhanced agreement to support the efforts of AIDS Drug Assistance Programs to provide antiretroviral medicines to people living with HIV and AIDS. Building on an agreement signed in March of 2010, today’s announcement marks a multi-year enhancement to assist ADAPs in meeting the challenges of increasing patient case loads and strained government funding.

Read more

Filed under: Pharmacy News
Tags: AIDS, Drug, HIV, medicine, Pharmacy

Related posts

• U-M scientists identify new reservoir for hidden HIV-infected cells that can serve as factory for new infections (0)
  University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for [...]
  
  
• Pros and cons of HIV treatments in developing countries (0)
  Palumbo is co-leading a clinical study of anti-HIV medicines in Africa and India for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT). The randomized trial found that a cohort of 82 HIV-infected children ages 6 to 35 months responded better to treatment with the protease-inhibiting drug lopinavir (LPV/r) than did a cohort of [...]
  
  
• HHS to give states $25 million for HIV drugs; Researchers identify antibodies that may help in AIDS vaccine research (0)
  Health and Human Services Secretary Kathleen Sebelius said Thursday "that she would provide $25 million more to help states buy life-saving medications for people with H.I.V. or AIDS. Advocates for patients said the money was not nearly enough to eliminate waiting lists, which have surged to record levels as people have lost health insurance, along [...]
  
  
• Bristol-Myers Squibb And ADAP Crisis Task Force Announce Enhanced, Multi-year Support For AIDS Drug Assistance Programs (ADAPs) In The United States (0)
  Bristol-Myers Squibb Company (NYSE: BMY) and the ADAP Crisis Task Force (ACTF) announced an enhanced agreement to support the efforts of AIDS Drug Assistance Programs (ADAPs) to provide antiretroviral medicines to people living with HIV and AIDS... Read more [tags] Pharmacy News [/tags]
  
  
• Bloomberg Businessweek explores growing trend in pharma to license, donate HIV drugs (0)
  "Pharmaceutical companies, once blasted as uncaring or downright greedy for charging thousands of dollars for a year's worth of AIDS medicines … in poor countries, lately have been slashing prices and licensing their drugs for free or nominal cost to nonprofits or local manufacturers in the developing world," Bloomberg BusinessWeek writes in an analysis piece [...]